March 28, 2024

eClinical Solutions Market Size to Reach US$ 20.8 billion by 2030

The global eclinical solutions market size was valued at USD 6.2 billion in 2020, and is predicted to be worth around USD 20.8 billion by 2030, registering a CAGR of 12.6% during the forecast period 2022 to 2030.

eClinical Solutions Market (By Product: Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment (eCOA), Safety Solutions, Electronic Trial Master File (eTMF); By Delivery Mode: Web-hosted (On demand), Licensed Enterprise (On premise), Cloud-based; By Development Phase: Phase I, Phase II, Phase III, Phase IV; By End-use: Hospitals/Healthcare providers, CROs, Academic Institutes, Pharma & Biotech Organizations, Medical Device Manufacturers) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/39114

Report Coverage

Report ScopeDetails
Market SizeUS$ 20.8 billion by 2030
Growth RateCAGR of 12.6% From 2022 to 2030
Largest MarketNorth America
Base Year2021
Forecast Period2022 to 2030
Segments CoveredProduct, Delivery mode, Development Phase, End-use

Growth Factors

Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel market growth. During the COVID-19 pandemic, clinical laboratories experienced high demand for COVID-19 tests. eClinical solutions, such as the clinical data management systems assisted these laboratories to seamlessly manage the huge influx of specimens daily. Technological advancements such as electronic data capture and Wi-Fi connectivity are projected to drive the market in the forthcoming years.

Increasing research and development activities by biopharma and pharma companies is one of the key trends escalating market growth. Besides this, the growing incorporation of software solutions in clinical trials is also projected to provide a fillip to the market. The COVID-19 pandemic boosts the adoption of the market, as companies in the market were investing in better healthcare IT solutions to help in tackling the pandemic.

Key Players

  • Datatrak International, Inc.
  • Oracle
  • Parexel International Corporation
  • Dassault Systemes
  • Bioclinica
  • CRF Health
  • ERT Clinical
  • eClinicalWorks
  • IBM Watson Health
  • Anju Life Sciences Software
  • eClinical Solutions

Market Segmentation

  • By Product
    • Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
    • Clinical Trial Management Systems (CTMS)
    • Clinical Analytics Platforms
    • Randomization and Trial Supply Management (RTSM)
    • Clinical Data Integration Platforms
    • Electronic Clinical Outcome Assessment (eCOA)
    • Safety Solutions
    • Electronic Trial Master File (eTMF)
  • By Delivery Mode
    • Web-hosted (On demand)
    • Licensed Enterprise (On premise)
    • Cloud-based
  • By Development Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • By End-use
    • Hospitals/Healthcare providers
    • CROs
    • Academic Institutes
    • Pharma & Biotech Organizations
    • Medical Device Manufacturers
  • Regional
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Netherlands
      • Sweden
      • Denmark
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Australia
      • New Zealand
      • Taiwan
      • Hong Kong
      • Singapore
      • Thailand
      • Vietnam
    • Central & South America
      • Brazil
      • Argentina
      • Chile
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Egypt
      • Qatar

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39114

Reasons to Purchase this Report:– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Development Phase Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global EClinical Solutions Market, By Product

7.1.  EClinical Solutions Market, by Product, 2021-2030

7.1.1.    Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)

7.1.1.1.        Market Revenue and Forecast (2019-2030)

7.1.2.    Clinical Trial Management Systems (CTMS)

7.1.2.1.        Market Revenue and Forecast (2019-2030)

7.1.3.    Clinical Analytics PlatDelivery Modes

7.1.3.1.        Market Revenue and Forecast (2019-2030)

7.1.4.    Randomization and Trial Supply Management (RTSM)

7.1.4.1.        Market Revenue and Forecast (2019-2030)

7.1.5.    Clinical Data Integration PlatDelivery Modes

7.1.5.1.        Market Revenue and Forecast (2019-2030)

7.1.6.    Electronic Clinical Outcome Assessment (eCOA)

7.1.6.1.        Market Revenue and Forecast (2019-2030)

7.1.7.    Safety Solutions

7.1.7.1.        Market Revenue and Forecast (2019-2030)

7.1.8.    Electronic Trial Master File (eTMF)

7.1.8.1.        Market Revenue and Forecast (2019-2030)

Chapter 8.  Global EClinical Solutions Market, By Delivery Mode

8.1.  EClinical Solutions Market, by Delivery Mode, 2021-2030

8.1.1.    Web-hosted (On demand)

8.1.1.1.        Market Revenue and Forecast (2019-2030)

8.1.2.    Licensed Enterprise (On premise)

8.1.2.1.        Market Revenue and Forecast (2019-2030)

8.1.3.    Cloud-based

8.1.3.1.        Market Revenue and Forecast (2019-2030)

Chapter 9.  Global EClinical Solutions Market, By Development Phase

9.1.  EClinical Solutions Market, by Development Phase, 2021-2030

9.1.1.    Phase I

9.1.1.1.        Market Revenue and Forecast (2019-2030)

9.1.2.    Phase II

9.1.2.1.        Market Revenue and Forecast (2019-2030)

9.1.3.    Phase III

9.1.3.1.        Market Revenue and Forecast (2019-2030)

9.1.4.    Phase IV

9.1.4.1.        Market Revenue and Forecast (2019-2030)

Chapter 10.      Global EClinical Solutions Market, By Application

10.1.        EClinical Solutions Market, by Application, 2021-2030

10.1.1.  Hospitals/Healthcare providers

10.1.1.1.      Market Revenue and Forecast (2019-2030)

10.1.2.  CROs

10.1.2.1.      Market Revenue and Forecast (2019-2030)

10.1.3.  Academic Institutes

10.1.3.1.      Market Revenue and Forecast (2019-2030)

10.1.4.  Pharma & Biotech Organizations

10.1.4.1.      Market Revenue and Forecast (2019-2030)

10.1.5.  Medical Device Manufacturers

10.1.5.1.      Market Revenue and Forecast (2019-2030)

Chapter 11.      Global EClinical Solutions Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product (2019-2030)

11.1.2.  Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.1.3.  Market Revenue and Forecast, by Development Phase (2019-2030)

11.1.4.  Market Revenue and Forecast, by Application (2019-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product (2019-2030)

11.1.5.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.1.5.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.1.5.4.      Market Revenue and Forecast, by Application (2019-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product (2019-2030)

11.1.6.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.1.6.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.1.6.4.      Market Revenue and Forecast, by Application (2019-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product (2019-2030)

11.2.2.  Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.2.3.  Market Revenue and Forecast, by Development Phase (2019-2030)

11.2.4.  Market Revenue and Forecast, by Application (2019-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product (2019-2030)

11.2.5.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.2.5.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.2.5.4.      Market Revenue and Forecast, by Application (2019-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product (2019-2030)

11.2.6.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.2.6.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.2.6.4.      Market Revenue and Forecast, by Application (2019-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product (2019-2030)

11.2.7.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.2.7.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.2.7.4.      Market Revenue and Forecast, by Application (2019-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product (2019-2030)

11.2.8.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.2.8.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.2.8.4.      Market Revenue and Forecast, by Application (2019-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product (2019-2030)

11.3.2.  Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.3.3.  Market Revenue and Forecast, by Development Phase (2019-2030)

11.3.4.  Market Revenue and Forecast, by Application (2019-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product (2019-2030)

11.3.5.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.3.5.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.3.5.4.      Market Revenue and Forecast, by Application (2019-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product (2019-2030)

11.3.6.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.3.6.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.3.6.4.      Market Revenue and Forecast, by Application (2019-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product (2019-2030)

11.3.7.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.3.7.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.3.7.4.      Market Revenue and Forecast, by Application (2019-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product (2019-2030)

11.3.8.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.3.8.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.3.8.4.      Market Revenue and Forecast, by Application (2019-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product (2019-2030)

11.4.2.  Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.4.3.  Market Revenue and Forecast, by Development Phase (2019-2030)

11.4.4.  Market Revenue and Forecast, by Application (2019-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product (2019-2030)

11.4.5.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.4.5.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.4.5.4.      Market Revenue and Forecast, by Application (2019-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product (2019-2030)

11.4.6.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.4.6.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.4.6.4.      Market Revenue and Forecast, by Application (2019-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product (2019-2030)

11.4.7.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.4.7.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.4.7.4.      Market Revenue and Forecast, by Application (2019-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product (2019-2030)

11.4.8.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.4.8.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.4.8.4.      Market Revenue and Forecast, by Application (2019-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product (2019-2030)

11.5.2.  Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.5.3.  Market Revenue and Forecast, by Development Phase (2019-2030)

11.5.4.  Market Revenue and Forecast, by Application (2019-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product (2019-2030)

11.5.5.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.5.5.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.5.5.4.      Market Revenue and Forecast, by Application (2019-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product (2019-2030)

11.5.6.2.      Market Revenue and Forecast, by Delivery Mode (2019-2030)

11.5.6.3.      Market Revenue and Forecast, by Development Phase (2019-2030)

11.5.6.4.      Market Revenue and Forecast, by Application (2019-2030)

Chapter 12.  Company Profiles

12.1.              Datatrak International, Inc.

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Oracle

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Parexel International Corporation

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Dassault Systemes

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Bioclinica

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              CRF Health

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              ERT Clinical

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              eClinicalWorks

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              IBM Watson Health

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Anju Life Sciences Software

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39114

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →